Cargando…
Single-dose tocilizumab blunts systemic inflammation in severe COVID-19 patients
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590611/ https://www.ncbi.nlm.nih.gov/pubmed/34785118 http://dx.doi.org/10.1016/j.jcrc.2021.11.001 |
| _version_ | 1784599016355397632 |
|---|---|
| author | de Roquetaillade, Charles Guillemin, Jérémie Picod, Adrien Mebazaa, Alexandre Kimmoun, Antoine Chousterman, Benjamin Glenn |
| author_facet | de Roquetaillade, Charles Guillemin, Jérémie Picod, Adrien Mebazaa, Alexandre Kimmoun, Antoine Chousterman, Benjamin Glenn |
| author_sort | de Roquetaillade, Charles |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8590611 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85906112021-11-15 Single-dose tocilizumab blunts systemic inflammation in severe COVID-19 patients de Roquetaillade, Charles Guillemin, Jérémie Picod, Adrien Mebazaa, Alexandre Kimmoun, Antoine Chousterman, Benjamin Glenn J Crit Care Article Elsevier Inc. 2022-04 2021-11-14 /pmc/articles/PMC8590611/ /pubmed/34785118 http://dx.doi.org/10.1016/j.jcrc.2021.11.001 Text en © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article de Roquetaillade, Charles Guillemin, Jérémie Picod, Adrien Mebazaa, Alexandre Kimmoun, Antoine Chousterman, Benjamin Glenn Single-dose tocilizumab blunts systemic inflammation in severe COVID-19 patients |
| title | Single-dose tocilizumab blunts systemic inflammation in severe COVID-19 patients |
| title_full | Single-dose tocilizumab blunts systemic inflammation in severe COVID-19 patients |
| title_fullStr | Single-dose tocilizumab blunts systemic inflammation in severe COVID-19 patients |
| title_full_unstemmed | Single-dose tocilizumab blunts systemic inflammation in severe COVID-19 patients |
| title_short | Single-dose tocilizumab blunts systemic inflammation in severe COVID-19 patients |
| title_sort | single-dose tocilizumab blunts systemic inflammation in severe covid-19 patients |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590611/ https://www.ncbi.nlm.nih.gov/pubmed/34785118 http://dx.doi.org/10.1016/j.jcrc.2021.11.001 |
| work_keys_str_mv | AT deroquetailladecharles singledosetocilizumabbluntssystemicinflammationinseverecovid19patients AT guilleminjeremie singledosetocilizumabbluntssystemicinflammationinseverecovid19patients AT picodadrien singledosetocilizumabbluntssystemicinflammationinseverecovid19patients AT mebazaaalexandre singledosetocilizumabbluntssystemicinflammationinseverecovid19patients AT kimmounantoine singledosetocilizumabbluntssystemicinflammationinseverecovid19patients AT choustermanbenjaminglenn singledosetocilizumabbluntssystemicinflammationinseverecovid19patients AT singledosetocilizumabbluntssystemicinflammationinseverecovid19patients |